Track insider trading activity from Pfizer executives and directors. Pfizer Inc. stands as a global leader in pharmaceuticals and biotechnology, notably recognized for its role as a vaccine provider during the COVID-19 pandemic and its focus on innovative medicines in areas like cancer. Key insiders include CEO and Chairman Dr. Albert Bourla, Chief Corporate Affairs Officer Sally Susman, and various members of its Board of Directors such as Shantanu Narayen, Ronald E. Blaylock, and Scott Gottlieb. While insider ownership of Pfizer stock is relatively low at 0.06%, trading activity among its officers and directors, including acquisitions, sales, and option exercises, is regularly reported.
Join Stockcircle to see more insider trades and be the first to know about new executive transactions.
Sign Up
Facing demands for cuts of its COVID and RSV vaccine sales, Moderna walked away from a massive patent fight with GSK without paying a single dollar. A clean cross-license clears...
StockCircle, 14 days ago
AI
AI Generated
Wall Street braced for another quarterly loss, but Moderna just reported $162 million in net profit. Multi-year government supply deals overseas drove $1.31 billion in sales, pr...
StockCircle, 16 days ago
AI
AI Generated
Pfizer NYSE: PFE reported third-quarter 2026 revenue of $16.6 billion and raised its full-year outlook, citing growth in non-COVID products, contributions from launched and acqu...
marketbeat.com, 19 days ago
Pfizer Inc. ( PFE ) Q3 2026 Earnings Call November 3, 2026 10:00 AM EST Company Participants Francesca DeMartino - Chief Investor Relations Officer Albert Bourla - Chairman of t...
seekingalpha.com, 19 days ago
To improve your user experience we use cookies. Privacy Policy
Necessary for the website to function.
Help us understand how you use our site.
Used to show relevant ads.